Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists

被引:56
作者
Ryman-Rasmussen, JP
Nichols, DE
Mailman, RB
机构
[1] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Med Chem, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA
[6] Purdue Univ, Sch Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
关键词
D O I
10.1124/mol.105.012153
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Structurally dissimilar dopamine D(1) receptor agonists were compared with dopamine in their ability to activate adenylate cyclase and to internalize hemagglutinin-tagged human D(1) receptors in a stably transfected human embryonic kidney cell line. Thirteen dopamine D(1) receptor agonists were selected rationally from three different structural classes: rigid fused ring compounds [dihydrexidine, dinapsoline, dinoxyline, apomorphine, and (5aR, 11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]-phenanthrene-9,10-diol (A86929)]; isochromans [(1R, 3S)-3-(1'adamantyl)-1-aminomethyl-3,4-dihydo-5,6-dihydroxy-1H-2-benzopyran (A77636) and (1R,3S)-3-phenyl-1aminomethyl-3,4-dihydo-5,6-dihydroxy-1H-2-benzopyran (A68930)]; and benzazepines [7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF38393), (+/-)-7,8-dihydroxy-3allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF77434), 6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3benzazepine (SKF82958), 3-methyl-6-chloro-7,8-hydroxy-1-[3-methylphenyl]-2,3,4,5-tetrahydro-]H-3- benzazepine (SKF83959), R(+)-6-chloro-7,8,-dihydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF82957), and R(+)-6-chloro-7,8,dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine SKF81297)]. The working hypothesis was that some agonists have differential effects on adenylate cyclase versus receptor internalization that could be correlated to the structural class of the agonist. First, the affinity for the hemagglutinin-hD(1) receptor and the intrinsic activity and potency of adenylate cyclase activation were determined for each compound. The internalization time course and internalization efficacy were then determined for each agonist. It was surprising that internalization efficacy was found to be independent of either agonist structural class or affinity. Only agonists that had both high adenylate cyclase functional potency and high intrinsic activity caused internalization. In addition, four agonists from two structural classes were identified that were capable of fully activating adenylate cyclase without eliciting an internalization response. This study provides the first extensive characterization of D(1) receptor internalization in response to structurally diverse agonists and, at least for the D(1) receptor, shows that functional selectivity is not predictable by simple structural examination. These data are consistent with the hypothesis that functional selectivity reflects subtle ligand-induced conformational changes as opposed to simple agonist trafficking among discrete receptor active states.
引用
收藏
页码:1039 / 1048
页数:10
相关论文
共 39 条
[1]   DOPAMINE D-1 RECEPTOR MECHANISMS IN THE COGNITIVE PERFORMANCE OF YOUNG-ADULT AND AGED MONKEYS [J].
ARNSTEN, AFT ;
CAI, JX ;
MURPHY, BL ;
GOLDMANRAKIC, PS .
PSYCHOPHARMACOLOGY, 1994, 116 (02) :143-151
[2]   TRANS-10,11-DIHYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINE - A HIGHLY POTENT SELECTIVE DOPAMINE-D1 FULL AGONIST [J].
BREWSTER, WK ;
NICHOLS, DE ;
RIGGS, RM ;
MOTTOLA, DM ;
LOVENBERG, TW ;
LEWIS, MH ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1756-1764
[3]   Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors - Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor [J].
Brinson, AE ;
Harden, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11939-11948
[4]   CONFORMATIONAL-ANALYSIS AND MOLECULAR MODELING OF 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINES, 4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINES, AND 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINES AS D1 DOPAMINE RECEPTOR LIGANDS [J].
CHARIFSON, PS ;
BOWEN, JP ;
WYRICK, SD ;
HOFFMAN, AJ ;
CORY, M ;
MCPHAIL, AT ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2050-2058
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist [J].
Chu, P ;
Murray, S ;
Lissin, D ;
vonZastrow, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27124-27130
[7]  
Comstock K E, 1997, Methods Mol Biol, V62, P207
[8]   Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum [J].
Corvol, JC ;
Studler, JM ;
Schonn, JS ;
Girault, JA ;
Hervé, D .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (05) :1585-1588
[9]   (1R,3S)-1-(AMINOMETHYL)-3,4-DIHYDRO-5,6-DIHYDROXY-3-PHENYL-1H-2-BENZOPYRAN - A POTENT AND SELECTIVE D1 AGONIST [J].
DENINNO, MP ;
SCHOENLEBER, R ;
ASIN, KE ;
MACKENZIE, R ;
KEBABIAN, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (11) :2948-2950
[10]   SYNTHESIS AND DOPAMINERGIC ACTIVITY OF 3-SUBSTITUTED 1-(AMINOMETHYL)-3,4-DIHYDRO-5,6-DIHYDROXY-1H-2-BENZOPYRANS - CHARACTERIZATION OF AN AUXILIARY BINDING REGION IN THE D1 RECEPTOR [J].
DENINNO, MP ;
SCHOENLEBER, R ;
PERNER, RJ ;
LIJEWSKI, L ;
ASIN, KE ;
BRITTON, DR ;
MACKENZIE, R ;
KEBABIAN, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2561-2569